Skip to main content
An official website of the United States government

NCI Community Oncology Research Program (NCORP)

The NCI Community Oncology Research Program (NCORP) is a national network of cancer care investigators, providers, academia, and other organizations that care for diverse populations in health systems.

The DCP Community Oncology and Prevention Trials Research Group administers this program.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About NCORP

The program brings cancer clinical trials and control and delivery studies to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.

Visit the NCORP Website

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Salami, Simpa Samuel

University Of Michigan At Ann Arbor
United States

Defining the Biological Arc of Grade Group 1 Prostate Cancer 5R37CA283857-03 Guillermo Marquez, Ph.D.
Salipante, Stephen J

University Of Washington
United States

Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations and methylation 1R33CA302385-01 Nicholas Hodges, Ph.D.
Salkowski, Lonie

University Of Wisconsin-Madison
United States

Defining and Optimizing Critical Interpretation Skills in Screening Mammography to Improve Cancer Detection 5R37CA262110-04 Guillermo Marquez, Ph.D.
Salman, Emad

Florida Assn Of Pediatric Tumor Prog
United States

The Florida Pediatric NCORP: NCI Community Oncology Research Program. 3UG1CA189973-11S1 Vanessa A. White, M.P.H.
Salman, Emad

Florida Assn Of Pediatric Tumor Prog
United States

The Florida Pediatric NCORP: NCI Community Oncology Research Program. 3UG1CA189973-11S1 Vanessa A. White, M.P.H.
Salvemini, Daniela

Saint Louis University
United States

Fingolimod and Ozanimod for the treatment and prevention of chemobrain 5R01CA261979-04 Rachel Altshuler, Ph.D.
Salvemini, Daniela

Saint Louis University
United States

Fingolimod and Ozanimod for the treatment and prevention of chemobrain 5R01CA261979-04 Rachel Altshuler, Ph.D.
Sanchez, Eduardo Vilar

University Of Tx Md Anderson Can Ctr
United States

Cancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome 5R01CA260761-04 Asad Umar, D.V.M., Ph.D.
Sanchez, Eduardo Vilar

University Of Tx Md Anderson Can Ctr
United States

iCAN PREVENT: MD Anderson International Cancer Prevention Clinical Trials Consortium 2UG1CA242609-07 Donald Johnsey
Sanchez, Eduardo Vilar

University Of Tx Md Anderson Can Ctr
United States

Cancer Immune-Interception for Lynch Syndrome 5R01CA257375-05 Asad Umar, D.V.M., Ph.D.
Sanda, Martin G

Emory University
United States

Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern 5U01CA113913-18 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Sanda, Martin G

Emory University
United States

Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern 5U01CA113913-18 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Sands, Stephen Alan

Sloan-Kettering Inst Can Research
United States

Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) 5R01CA283045-02 Marjorie Perloff, M.D.
Sands, Stephen Alan

Sloan-Kettering Inst Can Research
United States

Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) 5R01CA283045-02 Marjorie Perloff, M.D.
Sands, Stephen Alan

Sloan-Kettering Inst Can Research
United States

Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) 5R01CA283045-02 Marjorie Perloff, M.D.

Clinical Trials

Status

No matching Clinical Trials were found.

View All Clinical Trials